OR-NIKE
5.2.2020 20:02:11 CET | Business Wire | Press release
Today, NIKE, Inc. (NYSE: NKE), unveiled breakthrough innovation for athletes competing in the Tokyo 2020 Games, including footwear designed to provide runners with a measurable performance benefit for a new era of competition. The NEXT% platform, introduced by barrier-breaking marathoner Eliud Kipchoge, will now expand into new disciplines following its unparalleled success in distance running.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200205005708/en/
Ahead of the hottest Games on record, Nike also debuted progressive new collections featuring sustainable materials for all athletes. As the growing climate emergency continues to disrupt competition and training, Nike’s sustainable innovations signal the brand’s commitment to helping protect the future of the planet – and, consequently, the future of sport. Highlights include our most sustainably designed medal stand uniform in Team USA history, footwear built predominantly from recycled waste and lifestyle apparel that embraces the goal of a zero-carbon future.
“At Nike, we see sport’s greatest stage as our biggest opportunity to show the world what’s possible,” said NIKE, Inc. President and CEO John Donahoe. “After all, what’s at stake isn’t just records, but the future of sport itself. In Tokyo, we’ll help the world’s best reach new levels of performance with our revolutionary platform, while sharing real solutions for the barriers all athletes face under rapidly changing climate conditions.”
- Team USA Medal Stand Collection [link ] : This summer, Team USA will prove the power of sustainability during medal ceremonies. In Tokyo, U.S. medalists will take the podium in iconic Windrunner jackets reengineered with 100% recycled polyester, pants featuring 100% recycled nylon and recycled-rubber Nike Grind trim and the Nike Air VaporMax 2020, constructed with recycled manufacturing material and precision-knit uppers for minimal waste.
- Nike Air Zoom Alphafly NEXT% [link ] : Call it the ultimate test run: when Eliud Kipchoge broke the two-hour marathon barrier in Vienna this past October, he was wearing a prototype of the Nike Air Zoom Alphafly NEXT%. In Summer 2020, Nike’s newest race-day shoe makes its official debut with two new Nike Air Zoom pods, additional foam, an updated carbon fiber plate and an ultra-breathable upper – all adding up to improved cushioning and running economy.
- Nike Air Zoom BB NXT [link ]: Nike Basketball's new Air Zoom BB NXT is engineered to be as light and responsive as possible. With a new Nike Air Zoom pod system, exposed Nike React foam and a thin plate positioned above the foam, the shoe provides athletes with lightweight strength, optimized impact protection and outstanding energy return.
- Nike SB Skateboarding Kits [link ] : For skateboarding’s debut on this summer’s global stage, Nike SB will introduce kits on the forefront of sustainable design. Athletes representing Team USA, France and Brazil will compete in uniforms designed with 100% recycled polyester, pattern efficiency for minimal waste and bright, bold styling (crafted in collaboration with Dutch artist Parra) to celebrate each nation’s unique sport culture.
- Space Hippie [link ] : In addition to product developed for athletes participating in the Tokyo 2020 Games, Nike will launch this spring an exploratory footwear collection that redefines what’s possible with sustainable product design. Space Hippie is constructed by transforming scrap material from factory floors – what Nike’s design teams have called “space junk” – into a radical expression of circular design. Every detail of the Space Hippie capsule collection, from material choices to methods of make to packaging, was chosen with consideration for its environmental impact, adding up to Nike’s lowest carbon footprint footwear.
NIKE, Inc., based near Beaverton, Oregon, is the world’s leading designer, marketer and distributor of authentic athletic footwear, apparel, equipment and accessories for a wide variety of sports and fitness activities. Converse, a wholly-owned NIKE, Inc. subsidiary brand, designs, markets and distributes athletic lifestyle footwear, apparel and accessories. For more information, NIKE, Inc.’s earnings releases and other financial information are available on the Internet at http://investors.nike.com . Individuals can also visit http://news.nike.com and follow @NIKE.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200205005708/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Investor Supporting Japan’s Entertainment Industry, Yoshihiro Shimamura, to Visit France Workshop to be Held During the Cannes Film Festival28.4.2026 04:00:00 CEST | Press release
Shimamura Yoshihiro Film Planning Inc. (Head Office: Osaka, Japan; CEO: Yoshihiro Shimamura), a company engaged in film production and investment, will host a workshop in France during this year’s Cannes Film Festival, as part of its commitment to further advancing the entertainment industry. The company invests in leading entertainment-related businesses in Japan and places strong emphasis on long-term value creation. It identifies the cultural and entertainment sectors as high-growth areas and is actively involved in international co-productions as a core part of its film production activities. As a recent investment, the company acquired 2,000,000 shares of Hankyu Hanshin Holdings, Inc.—a major Japanese entertainment conglomerate known for producing content enjoyed across generations—and became a major shareholder (as of March 25, 2026). Through such investments, the company aims to support the global expansion of Japanese entertainment while exploring synergies with its own interna
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom